Literature DB >> 26421692

Computerised working-memory focused cognitive remediation therapy for psychosis--A preliminary study.

A Hargreaves1, R Dillon1, H Anderson-Schmidt1, A Corvin1, B Fitzmaurice1, M Castorina2, I H Robertson2, G Donohoe3.   

Abstract

BACKGROUND: Cognitive deficits are a core feature of schizophrenia and related psychotic disorders and are associated with decreased levels of functioning. Behavioural interventions have shown success in remediating these deficits; determining how best to maximise this benefit while minimising the cost is an important next step in optimising this intervention for clinical use. AIMS: To examine the effects of a novel working-memory focused cognitive remediation (CR) training on cognitive difficulties based on internet delivery of training and weekly telephone support.
METHOD: Participants with a diagnosis of psychosis (n=56) underwent either 8 weeks of CR (approximately 20 h) or 8 weeks of treatment as usual (TAU). General cognitive ability, working memory and episodic memory were measured both pre and post intervention for all participants.
RESULTS: In addition to improvements on trained working memory tasks, CR training was associated with significant improvements in two tests of verbal episodic memory. No association between CR and changes in general cognitive ability was observed. Effect sizes for statistically significant changes in memory were comparable to those reported in the literature based primarily on 1:1 training.
CONCLUSIONS: The cognitive benefits observed in this non-randomised preliminary study indicate that internet-based working memory training can be an effective cognitive remediation therapy. The successes and challenges of an internet-based treatment are discussed.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Cognitive remediation therapy; Memory; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26421692     DOI: 10.1016/j.schres.2015.09.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Efficacy of the Therapeutic Game "Trisquel" in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study.

Authors:  Adolfo Piñón-Blanco; Esperanza Vergara-Moragues; Olga Gutiérrez-Martínez; Patricia Fernández-Palleiro; Sonia Rodrigues; Daniela Rodrigues-Amorím; María Teresa Lage-López; Ana González-López; Teresa Velasquez; Mónica Amorim; Manuel Lloves-Moratinos; Isabel Viéitez-Fernández; Gerardo Sabio-Fernandez; Rebeca Graña-Torralba; Vanesa Vilar-Díaz; Indalecio Carrera-Machado; Jesús Cancelo-Martinez; Adelino Ferreira; Susana Cardoso; Tania Rivera-Baltanás; Francisco Otero-Lamas; José Manuel Olivares; Carlos Spuch
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 5.435

2.  Computerized cognitive remediation therapy effects on resting state brain activity and cognition in schizophrenia.

Authors:  Fengmei Fan; Yizhuang Zou; Yunlong Tan; L Elliot Hong; Shuping Tan
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

3.  Intermittent theta burst stimulation (iTBS) combined with working memory training to improve cognitive function in schizophrenia: study protocol for a randomized controlled trial.

Authors:  Jiaqi Song; Dan Liu; Meng Zhang; Huiqiu Wang; Shuping Tan
Journal:  Trials       Date:  2020-07-29       Impact factor: 2.279

4.  Can cognitive remediation therapy be delivered remotely? A review examining feasibility and acceptability of remote interventions.

Authors:  Shreya Jagtap; Sylvia Romanowska; Talia Leibovitz; Karin A Onno; Amer M Burhan; Michael W Best
Journal:  Schizophr Res Cogn       Date:  2022-01-25

5.  The effect of transcranial direct current stimulation combined with working memory training on working memory deficits in schizophrenic patients: study protocol for a randomized controlled trial.

Authors:  Xiaolin Zhu; Chao Huang; Hongzhen Fan; Fengmei Fan; Yanli Zhao; Meihong Xiu; Yunhui Wang; Yajun Li; Yunlong Tan; Zhiren Wang; Shuping Tan
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.